Blonanserin for the treatment of delirium patients at an emergency medical care center: An open-label study

Blonanserin for the treatment of delirium patients at an emergency medical care center: An open-label study

Highlights ► The aims of this study were to provide preliminary data on the usefulness and safety of blonanserin (BNS) in treating delirium patients in emergency rooms. ► We enrolled 9 subjects in the study and the Memorial Delirium Assessment Scale (MDAS) was used to evaluate the efficacy of BNS. ►...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Asian journal of psychiatry 2013-04, Vol.6 (2), p.182-183
Hauptverfasser: Kato, Koji, Akama, Fumiaki, Yamada, Keigo, Maehara, Mizuki, Kimoto, Keitaro, Kimoto, Kousuke, Takahashi, Yuki, Sato, Reiko, Matsumoto, Hideo
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Blonanserin
Critical Care - methods
Delirium
Delirium - drug therapy
Emergency room
Emergency Treatment - methods
Female
Humans
Intensive care unit
Internal Medicine
Male
Pilot Projects
Piperazines - therapeutic use
Piperidines - therapeutic use
Psychiatry
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights ► The aims of this study were to provide preliminary data on the usefulness and safety of blonanserin (BNS) in treating delirium patients in emergency rooms. ► We enrolled 9 subjects in the study and the Memorial Delirium Assessment Scale (MDAS) was used to evaluate the efficacy of BNS. ► MDAS scores were significantly reduced from 18.1 ± 1.9 before treatment to 8.3 ± 6.1 after treatment ( P < 0.05). ► BNS may be effective and safe in the treatment of delirium patients in emergency rooms.
ISSN:1876-2018
1876-2026
DOI:10.1016/j.ajp.2012.09.003